Product Information
DHIVY 25-100 MG TABLET is a brand product labeled by Avion Pharmaceuticals, LLC, priced at $3.6141 per EA under NDC 75854070101. Its NADAC has been published 124 times since May 22, 2024.
FDA first approved this application on Nov 12, 2021.
Strength
25; 100 mg/1; mg/1
Manufacturer
Avion Pharmaceuticals, LLCNDC
75854070101
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
1/1/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
New Drug (NDA)
FDA Application
NDA214869FDA Approved
11/12/2021
On Market Since
7/13/2022
Pharmacological Classes
Price Statistics
The NADAC for DHIVY 25-100 MG TABLET has been published 124 times since May 22, 2024, and over the history we have for it it has risen 15.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.6141 per EA |
|---|---|
| All-time high | $3.6141 (Sep 30, 2026) |
| All-time low | $3.1229 (Oct 23, 2024) |
| 52-week high | $3.6141 |
| 52-week low | $3.4420 |
| Median price | $3.4420 |
| Average price | $3.4141 |
| Largest weekly change | +9.9% (Jan 1, 2025) |
| Weeks tracked | 124 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Carbidopa Levodopa market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Avion Pharmaceuticals, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carbidopa Levodopa market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aromatic Amino Acid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DHIVY 25-100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DHIVY 25-100 MG TABLET, manufactured by Avion Pharmaceuticals, LLC, is $3.6141 per EA (NDC 75854070101), effective Sep 30, 2026.
How has the price of DHIVY 25-100 MG TABLET changed over time?
Over the history we have for it, the NADAC for DHIVY 25-100 MG TABLET has risen 15.7%. It has been tracked across 124 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for DHIVY 25-100 MG TABLET?
Since May 22, 2024, the NADAC for DHIVY 25-100 MG TABLET has ranged from a low of $3.1229 (Oct 23, 2024) to a high of $3.6141 (Sep 30, 2026), with a median of $3.4420 per EA.
Are there cheaper alternatives to DHIVY 25-100 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of DHIVY 25-100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures DHIVY 25-100 MG TABLET?
DHIVY 25-100 MG TABLET (NDC 75854070101) is labeled by Avion Pharmaceuticals, LLC, and CMS classifies it as a brand product.